PODD vs GKOS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PODD · Insulet$146.51 ▼ 6.16%
GKOS · Glaukos$224.41 ▲ 2.01%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PODD -54.3%
- GKOS +154.0%
Head to head
| Metric | PODD | GKOS |
|---|---|---|
| Price | $146.51 | $224.41 |
| Change today | ▼ 6.16% | ▲ 2.01% |
| Market cap | $10.16B | $13.28B |
| Return, 3 months | +2.6% | +23.7% |
| Return, year to date | -48.5% | +98.8% |
| Return, 1 year | -54.2% | +167.6% |
| P/E (TTM) | 23.9 | – |
| P/B | 6.4 | 18.5 |
| P/E percentile vs own 5y | 11th | 2nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +23.5% | +58.0% |
| Net profit growth (YoY) | +322.2% | +112.4% |
| Gross margin | 71.1% | 64.8% |
| Operating margin | 16.9% | -25.3% |
| Net margin | 12.3% | -24.6% |
| Return on equity | 26.0% | -22.8% |
| Analyst target vs. price | +13.5% | +5.8% |
| Analyst buy share | 56% | 100% |
| RSI (14) | 50 | 64 |
| 30-day volatility | 41.9% | 98.5% |
| Max drawdown, 1 year | -62.3% | -28.4% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- GKOS is the largest of the group by market value.
- GKOS has returned the most over the past year.
- GKOS is growing revenue fastest.
- PODD keeps the most profit per dollar of sales.
- PODD has been the calmest stock over the last 30 days.